Re-consent in Clinical Trials: Streamlining with eConsent
Learn about re-consent challenges, regulatory insights, and the role of eConsent in streamlining informed consent processes.
Learn about re-consent challenges, regulatory insights, and the role of eConsent in streamlining informed consent processes.
Learn unique approaches to study design and supply chain management to better navigate the complex landscape of rare disease clinical trials.
Explore how to keep your clinical trial data safe, secure, and protected in three key steps.
Navigating the unique complexities of rare disease research is challenging. Discover key strategies and solutions to support participants and reduce overall burden.
Uncover solutions for oncology trial success: conquer enrollment and retention obstacles, expedite timelines, and navigate global supply chains.
Learn unique approaches to study design and supply chain management to better navigate the complex landscape of rare disease clinical trials.
Understand how the European MDR (EU MDR) will impact medical device manufacturers and what you can do to prepare.
Data management in clinical research is at an inflection point. Learn what you can do to create more accurate, high-quality clinical trials.
The right EDC system can set researchers up for success in building faster, more robust trials. Read more to learn the essential EDC building blocks.
Digital data capture, such as electronic data capture (EDC), ePRO, and eConsent, create patient centricity and enable accurate data collection.
Understand the challenges with source data verification and learn how eSource affects clinical trials and improves data integrity.
Partnering with a reliable EDC vendor to ensure your clinical trial data meets high standards of accuracy and integrity is essential for passing FDA scrutiny. Risk-based approaches and improved monitoring workflows can help researchers stay ahead of the curve in navigating any potential challenges posed by the FDA, reducing the risk of warnings, rejections or costly additional research.
Sign up to have our the latest insights delivered to your inbox.